Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 10 (5)

Efficacy of a Gluten-Free Diet in the Gilles De La Tourette Syndrome: A Pilot Study


Efficacy of a Gluten-Free Diet in the Gilles De La Tourette Syndrome: A Pilot Study

Luis Rodrigo et al. Nutrients.


The Gilles de la Tourette syndrome (GTS) and Non-Coeliac Gluten Sensitivity (NCGS) may be associated. We analyse the efficacy of a gluten-free diet (GFD) in 29 patients with GTS (23 children; six adults) in a prospective pilot study. All of them followed a GFD for one year. The Yale Global Tics Severity Scale (YGTSS), the Yale-Brown Obsessive-Compulsive Scale—Self Report (Y-BOCS) or the Children’s Yale-Brown Obsessive-Compulsive Scale—Self Report (CY-BOCS), and the Cavanna’s Quality of Life Questionnaire applied to GTS (GTS-QOL) were compared before and after the GFD; 74% of children and 50% of adults were males, not significant (NS). At the beginning of the study, 69% of children and 100% of adults had associated obsessive-compulsive disorder (OCD) (NS). At baseline, the YGTSS scores were 55.0 ± 17.5 (children) and 55.8 ± 19.8 (adults) (NS), the Y-BOCS/CY-BOCS scores were 15.3, (standard deviation (SD) = 12.3) (children) and 26.8 (9.2) (adults) (p = 0.043), and the GTS-QOL scores were 42.8 ± 18.5 (children) and 64 ± 7.9 (adults) (p = 0.000). NCGS was frequent in both groups, with headaches reported by 47.0% of children and 83.6% of adults (p = 0.001). After one year on a GFD there was a marked reduction in measures of tics (YGTSS) (p = 0.001), and the intensity and frequency of OCD (Y-BOCS/CY-BOCS) (p = 0.001), along with improved generic quality of life (p = 0.001) in children and adults. In conclusion, a GFD maintained for one year in GTS patients led to a marked reduction in tics and OCD both in children and adults.

Keywords: Gilles de la Tourette syndrome (GTS); children and adults; gluten-free diet; motor and vocal/phonic tics; non-coeliac gluten sensitivity (NCGS); obsessive-compulsive disorder (OCD); one-year adherence.

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by 1 article


    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; Washington, DC, USA: 2013.
    1. Robertson M.M. A personal 35 year perspective on Gilles de la Tourette syndrome: Prevalence, phenomenology, comorbidities, and coexistent psychopathologies. Lancet Psychiatry. 2015;2:68–87. doi: 10.1016/S2215-0366(14)00132-1. - DOI - PubMed
    1. Cath D.C., Hedderly T., Ludolph A.G., Stern J.S., Murphy T., Hartmann A., Czernecki V., Robertson M.M., Martino D., Munchau A., et al. ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part I: Assessment. Eur. Child Adolesc. Psychiatry. 2011;20:155–171. doi: 10.1007/s00787-011-0164-6. - DOI - PMC - PubMed
    1. Hassan N., Cavanna A.E. The prognosis of Tourette syndrome: Implications for clinical practice. Funct. Neurol. 2012;27:23–27. - PMC - PubMed
    1. Robertson M.M., Eapen V., Cavanna A.E. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: A cross-cultural perspective. J. Psychosom. Res. 2009;67:475–483. doi: 10.1016/j.jpsychores.2009.07.010. - DOI - PubMed

MeSH terms